Sunshine Biopharma Stock (NASDAQ: SBFM) stock price, news, charts, stock research, profile.
Open | $0.882 |
Close | $0.807 |
Volume / Avg. | 14.381M / 902.366K |
Day Range | 0.750 - 0.890 |
52 Wk Range | 0.920 - 140.000 |
Market Cap | $805.567K |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 29 |
Short Interest | 74.12% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Sunshine Biopharma (NASDAQ: SBFM) through any online brokerage.
Other companies in Sunshine Biopharma’s space includes: Dermata Therapeutics (NASDAQ:DRMA), NeuBase Therapeutics (NASDAQ:NBSE), Bone Biologics (NASDAQ:BBLG), Quoin Pharmaceuticals (NASDAQ:QNRX) and Qualigen Therapeutics (NASDAQ:QLGN).
The latest price target for Sunshine Biopharma (NASDAQ: SBFM) was reported by Aegis Capital on Monday, August 7, 2023. The analyst firm set a price target for 2.60 expecting SBFM to rise to within 12 months (a possible 220.99% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Sunshine Biopharma (NASDAQ: SBFM) is $0.81 last updated April 25, 2024 at 7:59 PM EDT.
There are no upcoming dividends for Sunshine Biopharma.
Sunshine Biopharma’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Sunshine Biopharma.
Sunshine Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.